Committed to quality
Rapid service. Pharma solutions.
Nutra-Med Packaging LLC provides packaging services for the Pharmaceutical, OTC, medical device, diagnostics, and dietary supplement industries in the US and Canada. Our focus is on blister packaging, bottling, specialized kitting, cartoning, and serialization operations for a variety of dosage forms and devices.
One-third of our team is a Quality Control Specialist.
Nutra-Med Packaging has a diverse staff of over 500 team members. Our team brings many years of experience in the pharmaceutical industry in Quality Assurance, Operations, and Sales.
Our Leadership
Kathleen Tirch
Hany Salama
Kevin St Germaine
Anmarie Wheeldon
Matt Rayner
-
Hany joined Nutra-med Packaging as Chief Executive Officer in January 2026, leading the company’s strategic vision, growth initiatives, and operational execution. He has brought over 20 years of global experience in healthcare, biopharma, consumer health, and life sciences. Hany has held senior leadership roles at Johnson & Johnson, Merck, Roche, BASF, and McKesson. At Johnson & Johnson, he led end-to-end supply chain and manufacturing operations for major consumer brands in highly regulated environments. Most recently, as Senior Vice President and General Manager at McKesson, he oversaw biopharma services, private-label strategy, commercialization, and specialty distribution, driving growth and operational transformation across large-scale, mission-critical platforms.
-
Kevin St. Germaine joined Nutra-Med in March 2026 as Chief Financial Officer. With more than 25 years of financial leadership experience, he brings a proven ability to help organizations navigate complexity and adapt to change. Kevin specializes in aligning financial strategy with operational excellence to drive sustainable growth, efficiency, and resilience.
His expertise includes strategic planning, cash flow management, risk mitigation, project leadership, and process transformation. Kevin is passionate about leveraging technology and data to optimize performance and enable smarter, data-driven decision-making.
A collaborative leader and trusted advisor, Kevin builds strong cross-functional relationships, fosters accountability, and helps guide organizations toward long-term value creation. His leadership delivers clarity, stability, and sustainable financial results.
-
Kathleen is an experienced leader with a broad background in Quality, Manufacturing and Packaging for over 30 years. She has extensive managerial and technical expertise in the demanding GMP environments of pharmaceuticals, medical device, and consumer health. With this knowledge she leads her Quality teams to ensure that the products packaged at Nutra-Med meet all the quality standards set forth by both the customer and Nutra-Med. In her journey, excellence in quality has always been her goal.
Having a BS in Biology from Montclair State University, Kathleen has served as a team leader, project leader and chairperson for many successful projects over her career.
-
Anmarie joined Nutra-Med Packaging in June 2024 as Director of Human Resources and was promoted to Vice President of Human Resources effective April 1, 2026.
Anmarie is a seasoned Human Resources leader with more than 20 years of comprehensive experience spanning talent management, leadership development, organizational design, and diversity and inclusion.
As Vice President of Human Resources at Nutra-Med Packaging, LLC., Anmarie serves as a key business partner supporting operations across multiple pharmaceutical manufacturing sites and a workforce of more than 500 employees. She leads a broad portfolio of HR functions, including employee engagement, employee relations, performance management, compensation strategy, staffing, organizational development, and training. Her work ensures consistent compliance with regulatory requirements while advancing the company's culture, capabilities, and long‑term growth. Her prior experience includes serving as Director of Human Resources for Integrated DNA Technologies and Nobel Biocare, both operating companies within the Danaher Corporation.
-
Matt joins Nutra-Med in March 2026 as EVP Operations with 20 years of leadership experience. During his 22-year tenure with Legacy Pharma Solutions, Matt maintained full operational accountability across production, engineering and maintenance, supply chain, procurement, scheduling, and facilities management. He is widely respected for building high-performance operations through the disciplined application of Lean manufacturing and continuous improvement principles.
Throughout his career, Matt has successfully led large-scale transformation initiatives focused on waste elimination, process optimization, and standardization-delivering measurable improvements in efficiency, throughput, and overall cost performance. His leadership has consistently translated strategy into execution with sustainable results. A strong advocate for data-driven decision-making, Matt developed and implemented robust KPI tracking systems that improved visibility across operational functions. By aligning performance metrics with strategic objectives, he fostered a culture of accountability, transparency, and results.
Board of Directors
Miles Oliver
Ronald Blaylock
Paul Wituschek
Kunal Gupta
Marie Ffolkes
Hany Salama
-
Prior to launching GenNx360 Capital Partners, Ronald founded and managed Blaylock & Company, one of the top investment banking firms in the country. The firm underwrote and advised on over $150B in transactions in 2005 alone. Blaylock & Co. participated in transactions for a diverse, blue-chip roster of clients that included AT&T, Boeing, CIT, GE, Google, Time Warner, UPS, and Verizon, among other Fortune 500 companies.
Ronald serves on the boards of numerous corporate and non-profit organizations including Pfizer, W.R. Berkley, Inc., Carnegie Hall, and the New York University Board of Trustees. In 1999, Blaylock was voted Capital Raiser of the Year by Corporate Finance Magazine. More recently in 2005, he was named one of the Most Powerful Blacks on Wall Street by Black Enterprise Magazine and was also named Man of the Year by the Covenant House for his charity work with that organization.
Ronald earned his M.B.A. in Finance from New York University’s Stern School of Business and his B.S. in Finance from Georgetown University.
Prior to founding the investment banking firm in 1993, he held executive management positions with UBS and CitiGroup.
-
Marie Ffolkes is a Managing Partner of GenNx360. She joined GenNx360 in 2023, and is engaged in all facets of GenNx360’s investment activities and portfolio management. Previously, Ms. Ffolkes was a Founder and Chief Executive Officer of Axxelist, Inc., a technology real estate company. Prior to Axxelist, Inc., Ms. Ffolkes was Chief Executive Officer of TriMark USA, LLC, President Americas of Air Products &Chemicals (NYSE: APD), and held executive and senior management positions at Tenneco, Johnson Controls International plc, GE Healthcare and GE Capital. She currently serves on the boards of Valero Energy Corporation (NYSE: VLO), and Masco Corporation (NYSE: MAS).
Ms. Ffolkes holds a B.S. from the City University of New York and an M.B.A. from Columbia Business School.
GenNx360 Role:
• Driving strategies to build value
• Implementing the investment thesis alongside the management team
• Igniting top line growth
• Helping build a world class sales force
• Cost management
-
Miles is a member of the investment team at GenNx360 Capital Partners. Since joining GenNx360 in January 2024, Miles has played an integral role in M&A diligence and execution, driving growth across the GenNx360 portfolio. In addition to Nutra-Med, Miles currently works closely with Tensentric, Horsburgh & Scott, and Shenandoah.
Prior to joining GenNx360, Miles worked as an investment banker at Wells Fargo Securities.
Miles received his B.S. from Washington and Lee University.
-
Paul Wituschek is one of the most accomplished leaders and entrepreneurs in the global Healthcare and Pharma Services industry. He has served as an Executive and Board Member for leading global brands, ICON Clinical Research, Catalent Pharma Solutions, Penn Pharma / PCI Pharma and Wolters Kluwer Health. During his tenures the companies generated billions in shareholder value and continuous record market cap growth.
In 2019, leveraging his extensive network of global client, investor and industry relationships, Paul founded Expert Insights the leading global Advisory Services Firm and Expert Network supporting investors and companies in Pharma Services. With offices in the U.S. and London, Expert Insights offers a full range of services for its clients including Intelligence, Strategy, Deal Sourcing, Due Diligence, Transformation, Board Advisory and Retained Executive and Board Search. Clients are the worlds leading Private Equity Firms, Institutional Investors and Pharma Services companies.
Paul also serves as Chairman of LifeSci Ventures a global brand of companies providing services, technology solutions and growth capital to Life Sciences and Healthcare companies.
Paul serves on the Board of Directors and as an Advisor to CEOs and Boards at several private and publicly-held companies. He is considered one the world’s leading experts on the Pharma Services industry and has advised investors and companies on hundreds of value-creating deals and exits.
-
Hany joined Nutra-med Packaging as Chief Executive Officer in January 2026, leading the company’s strategic vision, growth initiatives, and operational execution. He has brought over 20 years of global experience in healthcare, biopharma, consumer health, and life sciences. Hany has held senior leadership roles at Johnson & Johnson, Merck, Roche, BASF, and McKesson. At Johnson & Johnson, he led end-to-end supply chain and manufacturing operations for major consumer brands in highly regulated environments. Most recently, as Senior Vice President and General Manager at McKesson, he oversaw biopharma services, private-label strategy, commercialization, and specialty distribution, driving growth and operational transformation across large-scale, mission-critical platforms.
-
Kunal Gupta is the former CEO of Nutra-Med Packaging, the company founded by his father, Mahesh Gupta. Over two decades, Kunal helped steer the company through its major phases of commercial and operational scale. Under his leadership, Nutra-Med successfully partnered with GenNx360 Capital Partners, and executed the strategic acquisition and integration of Legacy Pharma Solutions.
As a board member, Kunal continues to leverage his specialized institutional and sector knowledge to help guide Nutra-Med’s long-term value creation, commercial initiatives, and strategic growth trajectory.
Our Facilities
80 Pallet 2°C to 8°C Cold Chain Storage
+
29 Temperature Controlled Packaging Suites
+
11 Blister Packaging Lines
+
10 High-Speed Bottling Lines
+
8 Cartoning Lines
+
Cold Chain Controlled Substance Cage
80 Pallet 2°C to 8°C Cold Chain Storage + 29 Temperature Controlled Packaging Suites + 11 Blister Packaging Lines + 10 High-Speed Bottling Lines + 8 Cartoning Lines + Cold Chain Controlled Substance Cage
Best-in-class production facilities
cGMP COMPLIANCE
Nutra-Med's facility is registered with the FDA, DEA, and NJ State Health Dept. and is in compliance with cGMP, FDA, and DEA regulations. Nutra-Med's internal detailed SOP's are in place to ensure the quality of the products we package. We are proud of our SOP's and our customers appreciate them too.
VALIDATION
All of our packaging machines are validated and qualified (IQ, OQ & PQ). Nutra-Med works with its customers to prepare and execute custom validation protocols for new packaging processes. Nutra-Med also routinely partners with its customers to perform cleaning validations and verifications.
QUALITY
Our quality group receives the most current industry standards training and strives to build a culture that emphasizes quality at Nutra-Med. All production and packaging-related activities are monitored and approved by our Quality Assurance department.
FACILITY
Our production facilities are FDA registered, cGMP compliant, and licensed for DEA schedule III-V and L1 Chemical. The total facility footprint is 215,000 sqft, with 50,000 sqft in production facilities, 123,000 sq ft in finished good, bulk, and component warehousing, and an 80 pallet location coldchain 2 ℃ to 8 ℃ refrigerator.